by Sumeet Singh | Oct 18, 2018 | Company News, DEA, Federal Regulation
Pharma Solutions and QPharma Announce Partnership for Comprehensive DEA Compliance Software Solution Pharmaceutical compliance partnership allows manufacturers and distributors to more easily meet and exceed DEA due diligence requirements. Penn Valley, PA — October 5,...
by Sumeet Singh | Oct 9, 2018 | Industry News
DEA Insights from the 2018 DEA Diversion Conference Background In a letter dated May 23, 2018, AmerisourceBergen threatened to stop supply to Bernie’s Pharmacy because of “an elevated percentage of opioid purchasing…specifically, it was noted that in recent months...
by Sumeet Singh | Sep 19, 2018 | DEA, Federal Regulation, Opioid Tax, State Compliance Requirements
DEA Insights from the 2018 DEA Diversion Conference The DEA hosted a conference in San Antonio, TX that addressed multiple aspects of how those that manufacture, purchase, and/or sell controlled substances are regulated. Topic 1: Opioid Epidemic Will Glaspy – Special...
by Sumeet Singh | Sep 10, 2018 | Industry News, Vermont
Legal Importation from Canada via SB 175 Vermont – Is it Possible? Challenges to implementation of Vermont’s Importation program. Background on the Bill The Vermont bill permits the importation of Rx drugs from Canada per the following: Importing drugs from...
by Sumeet Singh | Aug 28, 2018 | DEA, Federal Regulation
DEA Limits Quotas Key Reductions, 2019 versus 2018 per HDA: ANPP 88% Codeine (for conversion) 90% Dihydrocodeine 90% Dihydromorphine* 74% Fentanyl 88% Hydrocodone (for conversion) 4% Hydrocodone (for sale) 89% Hydromorphone 90% Meperidine 58% Morphine (for sale) 93%...
